# Corrigendum: The synergistic effects of pyrotinib combined with adriamycin on HER2-positive breast cancer

**Authors:** Chaokun Wang, Shuzhen Deng, Jing Chen, Xiangyun Xu, Xiaochen Hu, Dejiu Kong, Gaofeng Liang, Xiang Yuan, Yuanpei Li, Xinshuai Wang

PMC · DOI: 10.3389/fonc.2025.1536374 · 2025-03-18

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** breast cancer (MESH:D001943)
- **Chemicals:** pyrotinib (MESH:C000622954), adriamycin (MESH:D004317)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11959698/full.md

---
Source: https://tomesphere.com/paper/PMC11959698